Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Hypokalaemia (serum potassium < 3.5 mmol/L)

Nephrology · Abnormal laboratory result · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 1 to 3% of the general population and of patients with CKD [1]

< 2.5 mmol/L, symptoms or ECG changes: emergency department

Detailed explanation and international comparison (in French): read it in English (machine translation)

2.5 to 3.4 mmol/L: tests

Laboratory tests

Urine tests (spot sample, same day, before any potassium replacement)

If hypertension: after correction of serum potassium

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (8)
  1. Clase CM, Carrero JJ, Ellison DH, et al. ; KDIGO Controversies Conference Participants. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97(1):42-61.
  2. Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135-R146.
  3. Kim MJ, Valerio C, Knobloch GK. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2023;107(1):59-70A.
  4. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : sous-chapitre 13-03 (urines) et acte 0327 (digoxine).
  5. Douillard C, Houillier P, Nussberger J, Girerd X. Consensus SFE/SFHTA/AFCE sur l'hyperaldostéronisme primaire, partie 2 : premières étapes diagnostiques. Version française de : Ann Endocrinol (Paris). 2016;77(3):192-201.
  6. Adler GK, Stowasser M, Correa RR, et al. Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2025;110(9):2453-2495 (erratum 2025;110(11):e3933-e3934).
  7. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit CISPLATINE HIKMA 1 mg/mL, solution à diluer pour perfusion, rubrique 4.8.
  8. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit MACROGOL BIOGARAN 10 g, poudre pour solution buvable, rubrique 4.8.